Testing effectiveness (Phase 2)Study completedNCT03861936What this trial is testingBOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle ProminenceWho this might be right forMasseter Muscle Prominence Allergan 150
Not applicableStudy completedNCT01821534What this trial is testingReliability of a Masseter Muscle Prominence Scale and Lower Facial Shape ClassificationWho this might be right forHealthy Volunteers Allergan 201
Large-scale testing (Phase 3)Study completedNCT06399718What this trial is testingAssess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult ParticipantsWho this might be right forMasseter Muscle Prominence AbbVie 207
Large-scale testing (Phase 3)Study completedNCT04073303What this trial is testingBOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle ProminenceWho this might be right forMasseter Muscle Prominence AbbVie 377
Large-scale testing (Phase 3)Study completedNCT06387394What this trial is testingAssess BOTOX Injections in Adult Participants for the Change of Masseter Muscle ProminenceWho this might be right forMasseter Muscle Prominence AbbVie 202
Large-scale testing (Phase 3)Study completedNCT06137287What this trial is testingAssess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult ParticipantsWho this might be right forMasseter Muscle Prominence AbbVie 259
Large-scale testing (Phase 3)Study completedNCT06068855What this trial is testingAssess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult ParticipantsWho this might be right forMasseter Muscle Prominence AbbVie 249